Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 23 studies | 29% ± 13% | |
classical monocyte | 11 studies | 23% ± 8% | |
myeloid cell | 9 studies | 30% ± 14% | |
microglial cell | 9 studies | 36% ± 16% | |
alveolar macrophage | 6 studies | 35% ± 18% | |
monocyte | 6 studies | 27% ± 6% | |
conventional dendritic cell | 5 studies | 21% ± 6% | |
dendritic cell | 5 studies | 25% ± 5% | |
mononuclear phagocyte | 4 studies | 25% ± 9% | |
epithelial cell of proximal tubule | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of TFEC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 98% | 1304.45 | 87 / 89 | 90% | 16.72 | 809 / 901 |
lung | 100% | 2094.96 | 577 / 578 | 81% | 3.66 | 940 / 1155 |
breast | 93% | 345.64 | 425 / 459 | 87% | 3.82 | 976 / 1118 |
intestine | 97% | 522.96 | 937 / 966 | 44% | 1.27 | 233 / 527 |
bladder | 90% | 254.62 | 19 / 21 | 43% | 1.40 | 219 / 504 |
esophagus | 70% | 168.98 | 1018 / 1445 | 54% | 1.70 | 99 / 183 |
stomach | 62% | 127.80 | 223 / 359 | 61% | 2.16 | 174 / 286 |
thymus | 72% | 188.56 | 468 / 653 | 49% | 1.25 | 294 / 605 |
brain | 40% | 97.32 | 1055 / 2642 | 74% | 2.54 | 521 / 705 |
adrenal gland | 96% | 407.57 | 248 / 258 | 17% | 0.28 | 40 / 230 |
ovary | 44% | 87.41 | 79 / 180 | 64% | 1.75 | 274 / 430 |
pancreas | 37% | 75.45 | 122 / 328 | 70% | 3.37 | 125 / 178 |
uterus | 59% | 101.90 | 101 / 170 | 45% | 1.18 | 208 / 459 |
prostate | 76% | 176.16 | 187 / 245 | 26% | 0.50 | 133 / 502 |
spleen | 100% | 1930.37 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 98% | 700.77 | 1185 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 14.26 | 28 / 29 |
peripheral blood | 83% | 432.05 | 769 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 81% | 310.41 | 1088 / 1335 | 0% | 0 | 0 / 0 |
skin | 26% | 41.35 | 470 / 1809 | 53% | 2.22 | 252 / 472 |
liver | 46% | 87.53 | 104 / 226 | 23% | 0.53 | 93 / 406 |
tonsil | 0% | 0 | 0 / 0 | 67% | 2.35 | 30 / 45 |
heart | 57% | 122.84 | 493 / 861 | 0% | 0 | 0 / 0 |
muscle | 13% | 18.27 | 106 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.13 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0034605 | Biological process | cellular response to heat |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046983 | Molecular function | protein dimerization activity |
Gene name | TFEC |
Protein name | Uncharacterized protein TFEC Transcription factor EC Transcription factor EC (TFE-C) (Class E basic helix-loop-helix protein 34) (bHLHe34) (Transcription factor EC-like) (hTFEC-L) |
Synonyms | TFECL BHLHE34 TCFEC |
Description | FUNCTION: Transcriptional regulator that acts as a repressor or an activator. Acts as a transcriptional repressor on minimal promoter containing element F (that includes an E-box sequence). Binds to element F in an E-box sequence-specific manner. Acts as a transcriptional transactivator on the proximal promoter region of the tartrate-resistant acid phosphatase (TRAP) E-box containing promoter (By similarity). Collaborates with MITF in target gene activation (By similarity). Acts as a transcriptional repressor on minimal promoter containing mu E3 enhancer sequence (By similarity). Binds to mu E3 DNA sequence of the immunoglobulin heavy-chain gene enhancer (By similarity). Binds DNA in a homo- or heterodimeric form. . |
Accessions | ENST00000457268.5 [O14948-4] ENST00000484212.5 Q75KY0 ENST00000265440.12 [O14948-1] B7Z757 O14948 Q75MG2 ENST00000393485.5 [O14948-3] ENST00000320239.11 [O14948-2] |